FI69308C - Foerfarande foer framstaellning av terapeutiskt anvaendbara spro-kinolylhydantoiner - Google Patents
Foerfarande foer framstaellning av terapeutiskt anvaendbara spro-kinolylhydantoiner Download PDFInfo
- Publication number
- FI69308C FI69308C FI800163A FI800163A FI69308C FI 69308 C FI69308 C FI 69308C FI 800163 A FI800163 A FI 800163A FI 800163 A FI800163 A FI 800163A FI 69308 C FI69308 C FI 69308C
- Authority
- FI
- Finland
- Prior art keywords
- formula
- acid
- compounds
- norm
- kinolylhydantoiner
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/20—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US527879 | 1979-01-22 | ||
| US06/005,278 US4176185A (en) | 1979-01-22 | 1979-01-22 | Spiro-quinolylhydantoins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI800163A FI800163A (fi) | 1980-07-23 |
| FI69308B FI69308B (fi) | 1985-09-30 |
| FI69308C true FI69308C (fi) | 1986-01-10 |
Family
ID=21715098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI800163A FI69308C (fi) | 1979-01-22 | 1980-01-21 | Foerfarande foer framstaellning av terapeutiskt anvaendbara spro-kinolylhydantoiner |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4176185A (ja) |
| EP (1) | EP0014079B1 (ja) |
| JP (1) | JPS5840959B2 (ja) |
| KR (1) | KR830001940A (ja) |
| AR (1) | AR222685A1 (ja) |
| AT (1) | AT365588B (ja) |
| AU (1) | AU514271B2 (ja) |
| CA (1) | CA1140928A (ja) |
| DE (1) | DE3060079D1 (ja) |
| DK (1) | DK156399C (ja) |
| EG (1) | EG15085A (ja) |
| ES (1) | ES8103090A1 (ja) |
| FI (1) | FI69308C (ja) |
| GR (1) | GR72408B (ja) |
| IE (1) | IE49365B1 (ja) |
| IL (1) | IL59177A (ja) |
| NO (1) | NO152172C (ja) |
| NZ (1) | NZ192650A (ja) |
| PH (1) | PH15472A (ja) |
| PT (1) | PT70716A (ja) |
| YU (1) | YU41692B (ja) |
| ZA (1) | ZA80344B (ja) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4176185A (en) * | 1979-01-22 | 1979-11-27 | Pfizer Inc. | Spiro-quinolylhydantoins |
| US4490381A (en) * | 1979-11-13 | 1984-12-25 | Imperial Chemical Industries Plc | 1'-Substituted spiro[imidazolidine-4,3'-indoline]2,2',5-triones |
| US4248882A (en) * | 1980-02-12 | 1981-02-03 | Pfizer Inc. | Treating diabetes-associated complications with hydantoin amines |
| JPS5745185A (en) * | 1980-07-21 | 1982-03-13 | Eisai Co Ltd | Hydantoin derivative and its preparation |
| DE3261684D1 (en) * | 1981-05-12 | 1985-02-07 | Ici Plc | Pyrrole derivatives |
| HU204832B (en) * | 1987-09-04 | 1992-02-28 | Pfizer | Process for producing spiro-(imidazolidine-4,4'-pyrano/2,3-b/pyridine) derivatives and pharmaceutical compositions comprising same |
| US5068333A (en) * | 1990-03-07 | 1991-11-26 | Pfizer Inc. | 6-chloro-3,4-dihydro-pyrano [2,3-b]pyridines having the R configuration |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1135915B (de) * | 1961-06-29 | 1962-09-06 | Asta Werke Ag Chem Fab | Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine |
| US3876659A (en) * | 1970-09-18 | 1975-04-08 | Sandoz Ag | Spiro tricyclic isoindolines |
| US4117230A (en) * | 1976-10-18 | 1978-09-26 | Pfizer Inc. | Hydantoin derivatives as therapeutic agents |
| US4176185A (en) * | 1979-01-22 | 1979-11-27 | Pfizer Inc. | Spiro-quinolylhydantoins |
-
1979
- 1979-01-22 US US06/005,278 patent/US4176185A/en not_active Expired - Lifetime
- 1979-12-28 NO NO794318A patent/NO152172C/no unknown
-
1980
- 1980-01-12 EG EG36/80A patent/EG15085A/xx active
- 1980-01-18 AT AT0026780A patent/AT365588B/de not_active IP Right Cessation
- 1980-01-18 CA CA000343984A patent/CA1140928A/en not_active Expired
- 1980-01-18 NZ NZ192650A patent/NZ192650A/en unknown
- 1980-01-18 DE DE8080300170T patent/DE3060079D1/de not_active Expired
- 1980-01-18 AR AR279683A patent/AR222685A1/es active
- 1980-01-18 YU YU131/80A patent/YU41692B/xx unknown
- 1980-01-18 EP EP80300170A patent/EP0014079B1/en not_active Expired
- 1980-01-21 ZA ZA00800344A patent/ZA80344B/xx unknown
- 1980-01-21 IL IL59177A patent/IL59177A/xx unknown
- 1980-01-21 DK DK024280A patent/DK156399C/da not_active IP Right Cessation
- 1980-01-21 IE IE109/80A patent/IE49365B1/en unknown
- 1980-01-21 PT PT70716A patent/PT70716A/pt not_active IP Right Cessation
- 1980-01-21 AU AU54766/80A patent/AU514271B2/en not_active Ceased
- 1980-01-21 KR KR1019800000213A patent/KR830001940A/ko unknown
- 1980-01-21 PH PH23529A patent/PH15472A/en unknown
- 1980-01-21 JP JP55005610A patent/JPS5840959B2/ja not_active Expired
- 1980-01-21 FI FI800163A patent/FI69308C/fi not_active IP Right Cessation
- 1980-01-22 ES ES487923A patent/ES8103090A1/es not_active Expired
- 1980-11-21 GR GR60999A patent/GR72408B/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0014079A1 (en) | 1980-08-06 |
| EG15085A (en) | 1986-12-30 |
| NO794318L (no) | 1980-07-23 |
| DK24280A (da) | 1980-07-23 |
| PT70716A (en) | 1980-02-01 |
| AT365588B (de) | 1982-01-25 |
| AU514271B2 (en) | 1981-01-29 |
| ES487923A0 (es) | 1981-02-16 |
| NZ192650A (en) | 1984-04-27 |
| IE49365B1 (en) | 1985-09-18 |
| ES8103090A1 (es) | 1981-02-16 |
| DK156399B (da) | 1989-08-14 |
| PH15472A (en) | 1983-01-24 |
| US4176185A (en) | 1979-11-27 |
| JPS55108873A (en) | 1980-08-21 |
| NO152172B (no) | 1985-05-06 |
| CA1140928A (en) | 1983-02-08 |
| AU5476680A (en) | 1980-07-31 |
| IL59177A0 (en) | 1980-05-30 |
| ZA80344B (en) | 1981-02-25 |
| GR72408B (ja) | 1983-11-02 |
| YU13180A (en) | 1983-01-21 |
| YU41692B (en) | 1987-12-31 |
| DK156399C (da) | 1990-01-08 |
| NO152172C (no) | 1985-08-14 |
| ATA26780A (de) | 1981-06-15 |
| AR222685A1 (es) | 1981-06-15 |
| KR830001940A (ko) | 1983-05-19 |
| IE800109L (en) | 1980-07-22 |
| IL59177A (en) | 1982-11-30 |
| DE3060079D1 (en) | 1982-01-21 |
| FI800163A (fi) | 1980-07-23 |
| JPS5840959B2 (ja) | 1983-09-08 |
| EP0014079B1 (en) | 1981-11-18 |
| FI69308B (fi) | 1985-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU1272984A3 (ru) | Способ получени производных фталазин-4-ил-уксусной кислоты или их солей | |
| FI62838C (fi) | Foerfarande foer framstaellning av den nya farmaceutiskt anvaendbara hoegerroterande isomeren av en asymmetriskt spiro-hydantoinfoerening | |
| SU1588283A3 (ru) | Способ получени производных хиназолина или их солей | |
| EP0264586B1 (en) | Hydantoin derivatives for treating complications of diabetes | |
| US4127665A (en) | Thienohydantoin derivatives | |
| EP0193415B1 (en) | Spiro-3-heteroazolidine compounds and salts thereof, their preparation and pharmaceutical agents thereof | |
| FI62307C (fi) | Foerfarande foer framstaellning av spiro(kroman- eller -tiokroman-4,4'-imidazolidin)-2' 5'-dioner och dylika tiokromaners oxidationsprodukter vilka aer anvaendbara vid behandling av diabetes | |
| CS199690B2 (cs) | Způsob výroby spiro-hydantoinových derivátů | |
| EP0091241A2 (en) | Condensed pyrrolinone derivatives, and their production | |
| CH690773A5 (de) | Pyrrolo(2,3-d)pyrimide und ihre Verwendung. | |
| US4181728A (en) | Spiro-polycyclicimidazolidinedione derivatives | |
| DK149569B (da) | Analogifremgangsmaade til fremstilling af isoquinolineddikesyre-forbindelser eller farmaceutisk acceptable salte deraf | |
| FI69308C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara spro-kinolylhydantoiner | |
| FI71139B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara haogensubstituerade bensonpyran- bensotiopyran- eller 2h-na ft/1,2-b/pyran-4-karboxylsyror | |
| DE19613550A1 (de) | Neue Pyrimido[1,2-a]indole | |
| SU858570A3 (ru) | Способ получени производных 3-/тетразол-5-ил/-1-азаксантона или их солей | |
| FI78699C (fi) | Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara spiro-imidazolidin-2,2',5-trionderivat. | |
| US4193996A (en) | Spiro-quinolone hydantoins | |
| WO1993013092A1 (en) | Imidazolidinedione derivatives | |
| JP2967231B2 (ja) | １，４―チアジン誘導体 | |
| US4327095A (en) | Methoxy derivatives of 1,4-dithiepino-[2,3-c]-pyrrole | |
| SU1189349A3 (ru) | Способ получени 6-замещенных гексагидроиндазолизохинолинов или их солей | |
| FI81575B (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara spiro-imidazolidin-4,3'-azaindolin-2,2',5 -trionderivat. | |
| FI77235B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara spiro-polycykliska imidazolidindionderivat. | |
| IE43551B1 (en) | Naphthyridine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: PFIZER INC. |